Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Day One Biopharmaceuticals, Inc. Common Stock (DAWN)

Pharmaceutical Preparations

https://www.dayonebio.com

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

2000 SIERRA POINT PARKWAY, SUITE 501
BRISBANE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/27/2021

Market Cap

1,242,688,680

Shares Outstanding

87,040,000

Weighted SO

87,042,933

Total Employees

N/A

Upcoming Earnings

08/05/2024

Beta

-1.5120

Last Div

0.0000

Range

9.67-18.07

Chg

-0.0700

Avg Vol

1006545

Mkt Cap

1242688680

Exch

NASDAQ

Country

US

Phone

650 484 0899

DCF Diff

11.3421

DCF

2.8879

Div Yield

0.0000

P/S

141.9891

EV Multiple

-3.3788

P/FV

4.0219

Div Yield %

0.0000

P/E

-7.3659

PEG

0.4251

Payout

0.0000

Current Ratio

4.0889

Quick Ratio

4.0873

Cash Ratio

2.5571

DSO

381.0146

DIO

45.8527

Op Cycle

426.8674

DPO

1956.7887

CCC

-1529.9213

Gross Margin

0.8627

Op Margin

-33.4242

Pretax Margin

-18.9589

Net Margin

-19.1362

Eff Tax Rate

-0.0726

ROA

-0.4182

ROE

-1.2270

ROCE

-0.9537

NI/EBT

1.0094

EBT/EBIT

0.5672

EBIT/Rev

-33.4242

Debt Ratio

0.0005

D/E

0.0006

LT Debt/Cap

0.0000

Total Debt/Cap

0.0006

Int Coverage

-84.4971

CF/Debt

-933.1263

Equity Multi

1.3055

Rec Turnover

0.9580

Pay Turnover

0.1865

Inv Turnover

7.9603

FA Turnover

24.3111

Asset Turnover

0.0219

OCF/Share

-2.0350

FCF/Share

-2.2666

Cash/Share

4.1536

OCF/Sales

-20.2575

FCF/OCF

1.1138

CF Coverage

-933.1263

ST Coverage

-933.1263

CapEx Coverage

-8.7878

Div&CapEx Cov

-8.7878

P/BV

4.0219

P/B

4.0219

P/S

141.9891

P/E

-7.3659

P/FCF

-6.2931

P/OCF

-6.9581

P/CF

-6.9581

PEG

0.4251

P/S

141.9891

EV Multiple

-3.3788

P/FV

4.0219

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation